Zytox Therapeutics AB
ActiveKey figures
Key figures
2025Summary: Zytox Therapeutics AB
What kind of company is it?
Zytox Therapeutics AB (org. no. 559359-4814) is a limited company (AB). The company was registered in 2022 and has existed for 4 years. Registered seat: Stockholm. Industry according to Statistics Sweden: other research and experimental development on natural sciences and engineering (SNI 72109).
How is the company doing financially?
The company had no net sales in financial year 2025. Financial year 2025 ended with a loss of 558 027 kr. At the end of financial year 2025, total assets were 1 405 656 kr and equity 1 375 752 kr (equity ratio 97,9 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 5 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Summary of annual reports2024–2025
| 2024 | 2025 | |
|---|---|---|
| Sales revenue | 0 | 0 |
| Profit for the reporting year | −1 097 980 | −558 027 |
| Retained earnings of previous periods | — | — |
| Total assets | 1 994 192 | 1 405 656 |
| Total liabilities | 60 413 | 29 904 |
| Total equity | 1 933 779 | 1 375 752 |
| Employees | — | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.